-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Reiterates Market Outperform on Nuvation Bio, Maintains $10 Price Target

Benzinga·09/16/2026 12:59:20
Listen to the news
Citizens analyst Silvan Turkcan reiterates Nuvation Bio (NYSE:NUVB) with a Market Outperform and maintains $10 price target.